Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00059865What this trial is testingGemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer Alliance for Clinical Trials in Oncology 68
Testing effectiveness (Phase 2)Study completedNCT00789958What this trial is testingS0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile DuctWho this might be right forExtrahepatic Bile Duct CancerGallbladder Cancer SWOG Cancer Research Network 105
Testing effectiveness (Phase 2)UnknownNCT06134193What this trial is testingCombination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract CancerWho this might be right forCarcinomaIntrahepatic CholangiocarcinomaGallbladder Cancer+5 more Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 41
Early research (Phase 1)Study completedNCT01242605What this trial is testingABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract CancerWho this might be right forBiliary Tract NeoplasmsCholangiocarcinomaGallbladder Neoplasms University College, London 13
Early research (Phase 1)Study completedNCT00987766What this trial is testingGemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+3 more Vanderbilt-Ingram Cancer Center 28
Early research (Phase 1)Study completedNCT00486356What this trial is testingCapecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more University of Nebraska 46
Testing effectiveness (Phase 2)Study completedNCT00009893What this trial is testingCombination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer Alliance for Clinical Trials in Oncology 42
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Not applicableUnknownNCT05718115What this trial is testingDeep Learning Radiogenomics For Individualized Therapy in Unresectable Gallbladder CancerWho this might be right forGallbladder Cancer Post Graduate Institute of Medical Education and Research, Chandigarh 75
Early research (Phase 1)WithdrawnNCT02105350What this trial is testingMEK162 With Gemcitabine and Oxaliplatin in Biliary CancerWho this might be right forBiliary Tract CarcinomaGallbladder Carcinoma University Health Network, Toronto
Testing effectiveness (Phase 2)Study completedNCT03201458What this trial is testingAtezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder CancerWho this might be right forGallbladder CarcinomaMetastatic CholangiocarcinomaStage III Intrahepatic Cholangiocarcinoma AJCC v8+2 more National Cancer Institute (NCI) 86
Large-scale testing (Phase 3)Study completedNCT00016380What this trial is testingOndansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenWho this might be right forCancer NCIC Clinical Trials Group 211
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT01572324What this trial is testingStudy of Hepatic Arterial Infusion to Treat Biliary Tract CarcinomasWho this might be right forBiliary Tract Cancer Peking University 37
Testing effectiveness (Phase 2)Study completedNCT01308840What this trial is testingGemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder CancerWho this might be right forBiliary Tract CancerGallbladder Cancer University of Rochester 31
Large-scale testing (Phase 3)Active Not RecruitingNCT05506943What this trial is testingCTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)Who this might be right forBiliary Tract CancerCholangiocarcinomaGall Bladder Cancer+1 more Compass Therapeutics 168
Testing effectiveness (Phase 2)Study completedNCT00084942What this trial is testingGemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the GallbladderWho this might be right forExtrahepatic Bile Duct CancerGallbladder Cancer Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT01425879What this trial is testingMK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by SurgeryWho this might be right forAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver CarcinomaRecurrent Adult Liver Carcinoma+5 more National Cancer Institute (NCI) 8
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24